abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Financing Cash Flow
-$48.23M
TTM · Period ending: · USD
HQL Financing Cash Flow
Latest reported-$48.23Mperiod ending
Latest reported-$48.23Mperiod ending
HQL Cash from Financing ($0.00 → -$48.23M)
Annual financing cash flow
High-resolution chart · PNG
HQL financing cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| -31,633,006 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 52,530 | |
| -9,436 | |
| -21,104,982 | |
| -118,300,000 | |
| -7,300,000 | |
| -7,600,000 | |
| -11,800,000 | |
| -10,600,000 | |
| 60,300,000 | |
| -7,300,000 | |
| -5,700,000 | |
| -5,900,000 | |
| -7,200,000 | |
| -8,100,000 | |
| -1,600,000 | |
| -6,300,000 | |
| 0 |